Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Features of CRISPR/Cas RNP delivery methods suitable for development of cell-based therapies and those considered ‘research-use only’.

More »

Fig 1 Expand

Fig 2.

Example of transfection plate layout.

Experiments where (A) optimal ratio of gRNA to CRISPR/Cas protein required for precomplexing will be determined, (B) the optimal amount of recombinant CRISPR/Cas will be determined (if we assume the optimal ratio will be 1:1) and (C) optimization of transfection reagent amount (1×, 2× and 3×) used for complex formation (if we assume the optimal CRISPR/Cas amount is 0.6 pmol per well). Wells named “T.R.” will contain transfection reagent only. White wells will hold non-transfected cells used as non-treated controls for the cell viability assay. The crossed-out wells represent empty wells used for holding the PrestoBlue™ Cell Viability Reagent staining blank. Grey wells will be filled with PBS to avoid edge effect. All experiments will be performed in triplicate, 4 gRNAs will be used for RNP formation (AAVS1, CDK4 and HPRT1 and non-targeting control gRNA).

More »

Fig 2 Expand

Fig 3.

Example of 20 μl Nucleocuvette™ Strip layout.

Experiments where (A) optimal ratio of gRNA to CRISPR/Cas protein required for precomplexing will be determined, (B) the optimal amount of recombinant CRISPR/Cas will be determined (if we assume the optimal ratio will be 1:1). All experiments will be performed in duplicate, 4 gRNAs will be used for RNP formation (AAVS1, CDK4 and HPRT1 and non-targeting control gRNA).

More »

Fig 3 Expand

Table 1.

CRISPR/Cas RNP delivery to immortalized cell lines and primary human cells using 4D-NucleofectorTM System.

More »

Table 1 Expand

Table 2.

CRISPR/Cas RNP delivery to target cells using Neon™ Transfection System.

More »

Table 2 Expand

Table 3.

NaCl and GABA concentrations optimization during iTOP protein transduction (48-well transduction plate layout).

More »

Table 3 Expand

Table 4.

Osmoprotectants concentrations optimization during iTOP protein transduction (48-well transduction plate layout).

More »

Table 4 Expand

Table 5.

Betaine and glycerol concentrations optimization during iTOP protein transduction (48-well transduction plate layout).

More »

Table 5 Expand

Table 6.

Proline and glycerol concentrations optimization during iTOP protein transduction (48-well transduction plate layout).

More »

Table 6 Expand

Table 7.

Glucose, sucrose and mannitol concentrations optimization for GSM protein transduction.

More »

Table 7 Expand

Table 8.

Sucrose and PEG1000 concentrations optimization during standard osmotic lysis of pinocytic vesicles technique (48-well transduction plate layout).

More »

Table 8 Expand